dopa/edema

O link é salvo na área de transferência

Escolha o tipo de classificação

Página 1 a partir de 43 resultados

[Keratitis and corneal edema associated with levodopa use--a case report].

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

We report a patient who developed keratitis and corneal edema during treatment with carbidopa-levodopa. The patient was a 34-year-old woman who complained of apraxic gait after anoxic brain damage caused by ventricular arrhythmia. She had difficulty in walking. While doses of droxidopa, flecainide

Rigidity and pulmonary edema after Innovar in a patient on Levodopa therapy: report of a case.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

[Idiopathic edema, tubular metabolism of water and sodium].

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

OBJECTIVE To look for intrinsic changes in renal tubular water and sodium metabolism in idiopathic edema (IE), independent of the underlying hormonal and vascular defects. METHODS Prospective controlled study in patients with edema referred to a nephrology clinic. METHODS Ten female patients with IE

Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The use of levodopa for treatment of Parkinson's disease is a well-established clinical practice. Data about the true incidence and severity of cutaneous complications associated with the use of levodopa are largely lacking. Aim of this review was to evaluate the quality of evidence referring to the

Levodopa treatment of late onset extrapyramidal movements in a child after high voltage electrocution.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

We present the case of a 12-year-old girl with abnormal extrapyramidal movements associated with basal ganglia lesions after electrical injury. After her injury, our patient initially did well and recovered from acute cardiovascular and hemodynamic instability, and the results of her neurological

Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Half of 94 parkinsonian patients improved on amantadine therapy during acute double-blind trials. In a four-year follow-up, amantadine given alone or added to a stable dose of levodopa had its greatest effect in the first month and helped few patients after six months. Levodopa either alone or added

Treatment of experimental cerebral infarction in rats with levodopa or with glycerol.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Administration of large amounts of levodopa did not improve survival rates of rats after acute cerebral infarction induced by injection of carbon microspheres. However, when 10% glycerol was used, the number of rats that survived after cerebral infarction was significantly greater than in the

[Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease].

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

A 77-year-old woman was admitted to our department due to leg edema of 2-year duration. The patient has been suffered from Parkinson's disease for 12 years and prescribed levodopa, selegiline, and small dosage of pergolide (200 microg/day). Leg edema developed one year after she took pergolide.

[Severe leg edema associated with the use of dopaminergic drugs in Parkinson's disease. Report of one case].

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The main adverse effects of dopaminergic drugs used in Parkinson's disease are hypotension, somnolence, hallucinations and impulse control disorder. Less common is leg edema. We report on a 68-year-old male receiving levodopa and pramipexole consulting for severe leg edema lasting two years, whose

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND The best way to initiate dopaminergic therapy for early Parkinson disease remains unclear. OBJECTIVE To compare initial treatment with pramipexole vs levodopa in early Parkinson disease, followed by levodopa supplementation, with respect to the development of dopaminergic motor

Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND The CALM-PD trial evaluated the development of motor complications in subjects with early Parkinson disease (PD) randomized to initial treatment with either pramipexole or levodopa. A secondary finding of the trial was a higher than anticipated development or worsening of somnolence and

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Medical treatment of levodopa-induced dyskinesia (LID) in Parkinson's disease (PD) is an unmet need. ADS-5102 (amantadine) extended-release capsules is being developed for the treatment of LID in patients with PD. Evaluate the long-term safety and tolerability of 274 mg ADS-5102 for LID in PD. In an

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

UNASSIGNED Medical treatment of levodopa-induced dyskinesia (LID) in Parkinson disease (PD) is an unmet need. UNASSIGNED To evaluate the efficacy and safety of ADS-5102 (amantadine) extended-release 274-mg capsules for treatment of LID in patients with PD. UNASSIGNED A randomized, double-blind,

Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The aim of this registry study in patients with Parkinson's Disease (PD) in treatment, was to evaluate the effects of Pycnogenol® supplementation on some accessory symptoms and cognitive functions (COFU).The registry included 43 PD patients who had been

Junte-se à nossa
página do facebook

Herbal & Natural Medicine

O mais completo banco de dados de ervas medicinais apoiado pela ciência

Funciona em 55 idiomas
Curas herbais apoiadas pela ciência
Reconhecimento de ervas por imagem
Mapa GPS interativo - marcar ervas no local (em breve)
Leia publicações científicas relacionadas à sua pesquisa
Pesquise ervas medicinais por seus efeitos
Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas